Arcturus Therapeutics, Inc.
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- arcturusrx.com
- Founded
- 2013
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Procure a pandemic influenza vaccine (PANDFLU) and a quadrivalent seasonal influenza vaccine (QSFLU) | Office of the Assistant Secretary for Preparedness and Response | $63,239,785 |
Quick answers
Is Arcturus Therapeutics, Inc. registered in SAM.gov?
Arcturus Therapeutics, Inc.'s SAM.gov registration expired on December 10, 2025.
What is Arcturus Therapeutics, Inc.'s CAGE code?
Arcturus Therapeutics, Inc.'s CAGE code is 6X1L5, and its Unique Entity ID (UEI) is E3MFDBN4L3J9.
What is Arcturus Therapeutics, Inc.'s most recent federal award?
Arcturus Therapeutics, Inc.'s most recent federal contract award is Procure a pandemic influenza vaccine (PANDFLU) and a quadrivalent seasonal influenza vaccine (QSFLU) (75A50122C00007), from Office of the Assistant Secretary for Preparedness and Response, on September 1, 2022.
On GovTribe
See Arcturus Therapeutics, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors